“We are very pleased to be working with Chris van Ingen,” comments Philippe Stas, CEO of Trinean. "His broad experience in the life science instrumentation field will be valuable to bring Trinean in its next phase of expansion.”
“Trinean’s fully integrated instrumentation platform offers excellent opportunities to automate and simplify many life sciences workflows”, Chris van Ingen adds, “and I am looking forward working with the Trinean board and management team.”
Currently, Chris is a director of the Bruker corporation, the Promega corporation and ProteinSimple corporation. Previously, Mr. van Ingen was president of Agilent Technologies’ Bio-Analytical Measurement Group. Between 1977 and 2001, Mr. van Ingen held several senior management positions at Hewlett Packard, including Vice President of Sales and Marketing of the Chemical Analysis group.